+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Preclinical examination of first and second generation photosensitizers used in photodynamic therapy



Preclinical examination of first and second generation photosensitizers used in photodynamic therapy



Photochemistry and Photobiology 54(6): 1093-1107



Numerous photosensitizers with absorption peaks spanning the 600-800 nm "therapeutic window" have been and continue to be synthesized. Structural modifications of the dyes can then be made in order to improve tumor deliverability and retention. Chemical alterations can also enhance the yields of light generated reactive oxygen species. Utilization of lipoproteins, emulsions and antibody conjugates can enhance the selectivity of drug localization. Most cell types and subcellular structures are highly photosensitive and biochemical analysis indicates that cellular target sites associated with PDT correlate with photosensitizer location. In vivo data suggest that vascular and direct tumor cell damage as well as systemic and local immunological reactions are involved in PDT responsiveness. Additional mechanistic, synthetic and developmental studies are required in order to fully appreciate the potentials of PDT. However, continued enthusiasm and support for basic PDT research (as observed during the past 8 years) will depend to a large extent on the outcome of the current clinical trials.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 032901001

Download citation: RISBibTeXText

PMID: 1775531

DOI: 10.1111/j.1751-1097.1991.tb02133.x


Related references

Current clinical and preclinical photosensitizers for use in photodynamic therapy. Journal of Medicinal Chemistry 47(16): 3897-3915, 2004

Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. Journal of Clinical Laser Medicine and Surgery 16(2): 81-91, 1998

Preclinical photodynamic therapy in Spain 1: Chemical and photophysical studies on porphycenes and other photosensitizers. Journal of Porphyrins and Phthalocyanines 13(04n05): 528-536, 2009

Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochemistry and Photobiology 85(5): 1053-1074, 2009

Preclinical photodynamic therapy in Spain 2: Liposome vectorization of photosensitizers; Different strategies, different outcomes. Journal of Porphyrins and Phthalocyanines 13(04n05): 537-543, 2009

Second generation photosensitizers for photodynamic therapy. Photochemistry & Photobiology 53(Suppl.): 103S, 1991

New photodynamic therapy with next-generation photosensitizers. Annals of Translational Medicine 5(8): 183, 2017

Preclinical photodynamic therapy research in Spain 3: Localization of photosensitizers and mechanisms of cell death in vitro. Journal of Porphyrins and Phthalocyanines 13(4n05): 544-551, 2009

Photodynamic Therapy Quantitative Data on 2nd and 3rd Generation Photosensitizers. Journal of Photochemistry and Photobiology B: Biology 52(1-3): 141-0, 1999

Photodynamic therapy novel third-generation photosensitizers one step closer?. British Journal of Pharmacology 154(1): 1-3, 2008

Preclinical photodynamic therapy research in Spain 4: Cytoskeleton and adhesion complexes of cultured tumor cells as targets of photosensitizers. Journal of Porphyrins and Phthalocyanines 13(04n05): 552-559, 2009

Photodynamic therapy: light delivery and dosage for second-generation photosensitizers. Ciba Foundation Symposium 146: 60-73; Discussion 73-7, 1989

P276 Photodynamic therapy in oral cancer patients with second-generation photosensitizers. Oral Oncology Suppl. 2(1): 215-216, 2007

Modified porphyrins, chlorins, phthalocyanines, and purpurins: second-generation photosensitizers for photodynamic therapy. Seminars in Hematology 26(2): 157-173, 1989

Photodynamic therapy Successful tumor destruction by second-generation photosensitizers in human colon carcinomas. Gastroenterology 104(4 Suppl. ): A405, 1993